PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-50.30%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-42.66%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-107.57%
Negative EBIT growth while 6617.T is at 176.08%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-114.45%
Negative operating income growth while 6617.T is at 23.88%. Joel Greenblatt would press for urgent turnaround measures.
-158.09%
Negative net income growth while 6617.T stands at 145.75%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-158.05%
Negative EPS growth while 6617.T is at 145.78%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-158.05%
Negative diluted EPS growth while 6617.T is at 145.92%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-85.07%
Negative 10Y revenue/share CAGR while 6617.T stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-85.07%
Negative 5Y CAGR while 6617.T stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
29.49%
3Y CAGR of 29.49% while 6617.T is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
100.00%
OCF/share CAGR of 100.00% while 6617.T is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
100.00%
OCF/share CAGR of 100.00% while 6617.T is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
100.00%
3Y OCF/share CAGR of 100.00% while 6617.T is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
96.50%
10Y net income/share CAGR of 96.50% while 6617.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
96.50%
Net income/share CAGR of 96.50% while 6617.T is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
78.40%
3Y net income/share CAGR of 78.40% while 6617.T is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
150.03%
Equity/share CAGR of 150.03% while 6617.T is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.83%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
71.44%
Inventory growth well above 6617.T's 8.09%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
20.47%
Positive asset growth while 6617.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-2.65%
We have a declining book value while 6617.T shows 0.43%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
67.11%
We have some new debt while 6617.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
No Data
No Data available this quarter, please select a different quarter.